Catalyst Watch: Spotlight on Tesla, Alphabet Earnings, AACR Drug Data, and Global PMI Reports
Eli Lilly Vows to Make Weight-Loss Pill in U.S. as Trump Pushes for Domestic Manufacturing -- Barrons.com
Eli Lilly and Company (LLY): One of the Best Long Term Stocks to Buy According to Billionaires
Daily short sale tracking: Petroleo Brasileiro SA Petrobras's short volume increased by 3 million, with a short sale ratio of 21%
Today's Analyst Rating | Evercore Upgrades Apple to Buy, Morgan Stanley Cuts Its Price Target Cut on Alphabet-C to $185
The "miracle weight loss drug" has entered the oral era. Will Eli Lilly and Co become the king of weight loss medications?
Wall Street Analysts generally believe that the GLP-1 weight loss medication field is transitioning from injectable forms to more convenient oral forms, and Eli Lilly and Co has already gained an early lead. This fierce, multi-year competition has clearly shown a winner; at least for now, Eli Lilly and Co has been crowned by the market as the new king in the realm of GLP-1 drugs.
74530746 : This cracks me up!!! You can’t even read English!!! you know what day it is